基于CT影像组学列线图预测头颈部鳞癌Ki-67指数
本研究构建并验证基于增强CT的影像组学列线图,用于预测头颈部鳞状细胞癌(HNSCC)Ki-67表达水平。共纳入217例患者,分为训练集(140例)和外部测试集(77例),采用LASSO筛选特征计算Rad-score,并结合临床因素构建列线图。列线图在训练集和测试集的AUC分别为0.919和0.832,优于临床模型,决策曲线分析显示临床效用更优。
要点
- 增强CT影像组学列线图可术前预测HNSCC的Ki-67指数(≥50% vs <50%)。
- 列线图结合Rad-score、低组织学分级和淋巴管扩散,预测效能优于临床模型。
- 训练集AUC 0.919,外部测试集AUC 0.832,具有较好泛化能力。
局限性
- 单中心回顾性研究,可能存在选择偏倚。
- 外部测试集样本量有限(77例),需更大规模多中心验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To construct and validate a contrast-enhanced computed tomography (CECT)-based radiomics nomogram to predict Ki-67 expression level in head and neck squamous cell carcinoma (HNSCC).
METHODS: A total of 217 patients with HNSCC who underwent CECT scans and immunohistochemical examination of their Ki-67 index were enrolled in this study. The patients were divided into a training set (n = 140; Ki-67: ≥ 50% [n = 72] and < 50% [n = 68]) and an external test set (n = 77; Ki-67: ≥ 50% [n = 38] and < 50% [n = 39]). The least absolute shrinkage and selection operator method was used to select key features for a CECT-image-based radiomics signature and a radiomics score (Rad-score) was calculated. A clinical model was established using clinical data and CT findings. The independent clinical factors and Rad-score were then combined to construct a radiomics nomogram. The performance characteristics of the Rad-score, clinical model, and nomogram were assessed using ROCs and decision curve analysis.
RESULTS: Twenty features were finally selected to construct the Rad-score. The radiomics nomogram incorporating the Rad-score, low histological grade, and lymphatic spread showed higher predictive value for the Ki-67 index (≥ 50% vs. < 50%) than the clinical model on both the training (AUC, 0.919 vs. 0.648, p < 0.001) and test (AUC, 0.832 vs. 0.685, p = 0.030) sets. Decision curve analysis demonstrated that the radiomics nomogram was more clinically useful than the clinical model.
CONCLUSIONS: A CECT-based radiomics nomogram was constructed to predict the expression of Ki-67 in HNSCC. This model showed favorable predictive efficacy and might be useful for prognostic evaluation and clinical decision-making in patients with HNSCC.
KEY POINTS: • Accurate pre-treatment prediction of Ki-67 index in HNSCC is crucial. • A CECT-based radiomics nomogram showed favorable predictive efficacy in estimation of Ki-67 expression status in HNSCC patients.
引用
- Zheng, Chen, Zhang, et al. CT radiomics nomogram for prediction of the Ki-67 index in head and neck squamous cell carcinoma. Eur Radiol. 2022. PMID: 36222864. doi:10.1007/s00330-022-09168-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。